High efficiency non-viral transfection of retinal and iris pigment epithelial cells with pigment epithelium-derived factor.
- Published in:
- Gene Therapy, 2010, v. 17, n. 2, p. 181, doi. 10.1038/gt.2009.124
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2010 AND VI 17 AND IP 2
Results: 16
1
2
Cellular effects of oncolytic viral therapy on the glioblastoma microenvironment.
- Published in:
- Gene Therapy, 2010, v. 17, n. 2, p. 202, doi. 10.1038/gt.2009.130
- By:
- Publication type:
- Article
3
In vivo selection of human embryonic stem cell-derived cells expressing methotrexate-resistant dihydrofolate reductase.
- Published in:
- Gene Therapy, 2010, v. 17, n. 2, p. 238, doi. 10.1038/gt.2009.131
- By:
- Publication type:
- Article
4
Lister strain vaccinia virus, a potential therapeutic vector targeting hypoxic tumours.
- Published in:
- Gene Therapy, 2010, v. 17, n. 2, p. 281, doi. 10.1038/gt.2009.132
- By:
- Publication type:
- Article
5
A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating γ-retroviral vectors using targeted integration.
- Published in:
- Gene Therapy, 2010, v. 17, n. 2, p. 272, doi. 10.1038/gt.2009.134
- By:
- Publication type:
- Article
6
Integrase-defective lentiviral vectors: progress and applications.
- Published in:
- Gene Therapy, 2010, v. 17, n. 2, p. 150, doi. 10.1038/gt.2009.135
- By:
- Publication type:
- Article
7
The impact of antigen expression in antigen-presenting cells on humoral immune responses against the transgene product.
- Published in:
- Gene Therapy, 2010, v. 17, n. 2, p. 288, doi. 10.1038/gt.2009.125
- By:
- Publication type:
- Article
8
Targeting human glioma cells using HSV-1 amplicon peptide display vector.
- Published in:
- Gene Therapy, 2010, v. 17, n. 2, p. 250, doi. 10.1038/gt.2009.128
- By:
- Publication type:
- Article
9
Effect of nuclear localization and hydrodynamic delivery-induced cell division on φC31 integrase activity.
- Published in:
- Gene Therapy, 2010, v. 17, n. 2, p. 217, doi. 10.1038/gt.2009.136
- By:
- Publication type:
- Article
10
In vitro and in vivo functional characterization of gutless recombinant SV40-derived CFTR vectors.
- Published in:
- Gene Therapy, 2010, v. 17, n. 2, p. 227, doi. 10.1038/gt.2009.137
- By:
- Publication type:
- Article
11
DNA prime–protein boost increased the titer, avidity and persistence of anti-Aβ antibodies in wild-type mice.
- Published in:
- Gene Therapy, 2010, v. 17, n. 2, p. 261, doi. 10.1038/gt.2009.140
- By:
- Publication type:
- Article
12
Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy.
- Published in:
- Gene Therapy, 2010, v. 17, n. 2, p. 190, doi. 10.1038/gt.2009.142
- By:
- Publication type:
- Article
13
DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes.
- Published in:
- Gene Therapy, 2010, v. 17, n. 2, p. 171, doi. 10.1038/gt.2009.143
- By:
- Publication type:
- Article
14
Single-cycle viral gene expression, rather than progressive replication and oncolysis, is required for VSV therapy of B16 melanoma.
- Published in:
- Gene Therapy, 2010, v. 17, n. 2, p. 158, doi. 10.1038/gt.2009.161
- By:
- Publication type:
- Article
15
The battle to prevent the transmission of mitochondrial DNA disease: Is karyoplast transfer the answer?
- Published in:
- Gene Therapy, 2010, v. 17, n. 2, p. 147, doi. 10.1038/gt.2009.164
- By:
- Publication type:
- Article
16
Progress and prospects: immune responses to viral vectors.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice